| 0.3 |
0.8 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 0.1 |
0.3 |
GO:2001037 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.1 |
1.3 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.2 |
GO:0031106 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.3 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 |
0.1 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.2 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.0 |
0.1 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.0 |
0.2 |
GO:0071651 |
positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.1 |
GO:0048372 |
lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.0 |
GO:2000543 |
positive regulation of gastrulation(GO:2000543) |
| 0.0 |
0.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
0.1 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.2 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.1 |
GO:2000639 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.0 |
0.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.1 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.0 |
0.1 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.0 |
0.2 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.0 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
